Alumis is a biotechnology company focused on targeted therapies for immune‑mediated diseases.
Investment category: Biotechnology
Ensho Therapeutics, Inc.
Ensho is a biotechnology company developing oral, small‑molecule therapies for inflammatory bowel disease.
Whitehawk Therapeutics
Whitehawk is an antibody drug conjugate (ADC)-focused biotechnology company advancing various cancer indications.
Arbor Biotechnologies, Inc.
Arbor is a biotechnology company advancing gene editing therapeutics to address genetic diseases.
Endeavor Biomedicines, Inc
Endeavor is a biotechnology company focused on medicines for idiopathic pulmonary fibrosis.
Epicrispr Biotechnologies, Inc.
Epicrispr is a biotechnology company pioneering gene-modulating therapies, leading with treatments for neuromuscular diseases.
Luoxin Pharmaceuticals Group Stock Co., Ltd
Luoxin Pharmaceuticals is a healthcare conglomerate engaged in pharmaceutical research and development, manufacture, sales, and healthcare service in China.
Profound Bio Inc.
ProfoundBio is an antibody drug conjugate (ADC)-focused biotechnology company advancing the treatment of cancers.
Shoreline Biosciences, Inc
Shoreline is a biotechnology company developing iPSC‑derived cell therapies for cancers.
Sonoma Biotherapeutics, Inc
Sonoma is a biotechnology company developing targeted and durable regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases.